We can attribute ArQule stock's powerful performance last month to Merck's (NYSE:MRK) Dec. 9 announcement that it plans to acquire ArQule. Shares surged to a closing gain of 104% that day.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,